We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.4B
AUM Growth
-$79M
Cap. Flow
-$151M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.15%
Holding
1,305
New
241
Increased
339
Reduced
426
Closed
291

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$166M
2
BNS icon
Scotiabank
BNS
+$139M
3
TD icon
Toronto Dominion Bank
TD
+$129M
4
CVE icon
Cenovus Energy
CVE
+$117M
5
PBA icon
Pembina Pipeline
PBA
+$89.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$85.9M
2
NVDA icon
NVIDIA
NVDA
+$70.9M
3
CIXX
CI Financial Corp.
CIXX
+$70.7M
4
MSFT icon
Microsoft
MSFT
+$68.2M
5
GRP.U
Granite Real Estate Investment Trust
GRP.U
+$63.1M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Technology 13%
3 Energy 12.62%
4 Industrials 11.87%
5 Materials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
901
Puma Biotechnology
PBYI
$450M
$261K ﹤0.01%
90,731
-9,484
-9% -$24.5K
HUBS icon
902
HubSpot
HUBS
$12B
$259K ﹤0.01%
+546
New +$265K
PTC icon
903
PTC
PTC
$16.7B
$259K ﹤0.01%
2,408
-22,582
-90% -$2.54M
BCEL
904
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$259K ﹤0.01%
+81,751
New +$198K
FBIZ icon
905
First Business Financial Services
FBIZ
$601M
$257K ﹤0.01%
7,841
-2,425
-24% -$78.2K
BLUE
906
DELISTED
bluebird bio
BLUE
$254K ﹤0.01%
+2,619
New +$346K
CVI icon
907
CVR Energy
CVI
$3.58B
$254K ﹤0.01%
+9,964
New +$207K
ALPN
908
DELISTED
Alpine Immune Sciences Inc
ALPN
$254K ﹤0.01%
28,316
+9,290
+49% +$80.3K
STOK icon
909
Stoke Therapeutics
STOK
$2.02B
$252K ﹤0.01%
11,957
+2,562
+27% +$51.3K
TCFC
910
DELISTED
The Community Financial Corporation Common Stock
TCFC
$248K ﹤0.01%
6,195
-2,144
-26% -$85.6K
DLTH icon
911
Duluth Holdings
DLTH
$151M
$246K ﹤0.01%
20,112
-2,076
-9% -$29K
IMVT icon
912
Immunovant
IMVT
$8.64B
$246K ﹤0.01%
44,668
-110,373
-71% -$687K
GBT
913
DELISTED
Global Blood Therapeutics, Inc.
GBT
$246K ﹤0.01%
7,103
-12,796
-64% -$383K
WNEB icon
914
Western New England Bancorp
WNEB
$282M
$245K ﹤0.01%
27,433
+1,069
+4% +$9.7K
TKC icon
915
Turkcell
TKC
$4.72B
$242K ﹤0.01%
+62,263
New +$222K
OSPN icon
916
OneSpan
OSPN
$624M
$239K ﹤0.01%
+16,549
New +$250K
PFBC icon
917
Preferred Bank
PFBC
$1.28B
$239K ﹤0.01%
3,230
-5,974
-65% -$463K
CBD
918
DELISTED
Companhia Brasileira de Distribuicao
CBD
$239K ﹤0.01%
47,519
-226,684
-83% -$962K
OFG icon
919
OFG Bancorp
OFG
$2.26B
$235K ﹤0.01%
8,815
-387
-4% -$10.8K
SIBN icon
920
SI-BONE Inc
SIBN
$849M
$235K ﹤0.01%
10,378
-3,727
-26% -$77.3K
XENE icon
921
Xenon Pharmaceuticals
XENE
$6.21B
$234K ﹤0.01%
+7,658
New +$229K
NXTC icon
922
NextCure
NXTC
$37.9M
$232K ﹤0.01%
3,971
-190
-5% -$11.9K
MMX
923
DELISTED
Maverix Metals Inc. Common Shares
MMX
$232K ﹤0.01%
+48,521
New +$224K
WSC icon
924
WillScot Mobile Mini Holdings
WSC
$4.17B
$229K ﹤0.01%
5,864
-182,643
-97% -$6.87M
TFX icon
925
Teleflex
TFX
$5.82B
$226K ﹤0.01%
+638
New +$210K
35 36
37
38 39

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 Portfolio in Review

As of Q1 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,305 positions worth $20.4B, down 0.39% from $20.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 filing shows 241 new, 339 increased, 426 reduced and 291 closed positions. Its largest new stake was CVS Health: 264,540 shares worth $26.8M. The largest sale was Cameco, an estimated $85.9M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2022 buy was CVS Health: 264,540 shares worth $26.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q1 2022, an estimated $166M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2022 reduction was Cameco, cutting an estimated $85.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $21.5M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 31% of its $20.4B portfolio in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 241 new positions and closed 291 in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 0.39% quarter-over-quarter to $20.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.